Darbepoetin Use for the Treatment of Anemia in Hemodialysis Patients in Saudi Arabia

Erythropoietin replacing proteins have improved patient outcomes and quality of life. Darbepoetin has a 3-fold longer half-life than recombinant human erythropoietin (rHuEPO). In this study, we investigate the efficacy and safety of the conversion of stable hemodialysis patients from the current sho...

Full description

Bibliographic Details
Main Authors: Shaheen Faissal, Akeel Nabila, Alfi Adnan, Harbi Ali, Tarif Nauman, Souqiyyeh Mohammad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2006-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Subjects:
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2006;volume=17;issue=3;spage=365;epage=372;aulast=Shaheen